Produkty 144490-63-1

CAS 144490-63-1 występuje w naszej ofercie pod nazwami: Tacrolimus 19-epimer,Tacrolimus EP Impurity G, Tacrolimus Impurity 4, 19-Epi FK-506 (Tacrolimus Impurity), Tacrolimus Impurity 8（Tacrolimus EP Impurity G）（Tacrolimus 19-Epimer）, 19-Epi fk-506. Oferty producentów: Chemat Brand, Hubei YoungXin, Biosynth, Chemat. Dostępne opakowania: on request, 10mg, 25mg, 50mg, 100mg, 200mg, 1mg, 2mg.

Tacrolimus 19-epimer,Tacrolimus EP Impurity G
Chemat Brand
  • opakowanie: on request
  • Warianty: 1
Zobacz produkt
Tacrolimus Impurity 4
Chemat Brand
  • opakowanie: on request
  • Warianty: 1
Zobacz produkt
19-Epi FK-506 (Tacrolimus Impurity)
Chemat Brand
  • opakowanie: on request
  • Warianty: 1
Zobacz produkt
Tacrolimus Impurity 8（Tacrolimus EP Impurity G）（Tacrolimus 19-Epimer）
Hubei YoungXin
  • opakowanie: 10mg, 25mg, 50mg, 100mg
  • Warianty: 5
Zobacz produkt
19-Epi fk-506
Biosynth
  • opakowanie: 1mg, 2mg, 5mg, 25mg
  • Warianty: 5
Zobacz produkt
19-Epi FK-506, 95%, 95%
Chemat
  • opakowanie: 10mg, 25mg
  • Warianty: 2
od 9568,40
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(1S,9S,12S,13R,14S,17R,18E,21S,23S,24R,25S,27R)-1,14-dihydroxy-12-[(E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-17-prop-2-enyl-11,28-dioxa-4-azatricyclo[22.3.1.04,9]octacos-18-ene-2,3,10,16-tetrone (CAS 144490-63-1) to związek chemiczny o wzorze sumarycznym C44H69NO12 i masie molowej 804.0 g/mol. Nazwa systematyczna IUPAC: (1S,9S,12S,13R,14S,17R,18E,21S,23S,24R,25S,27R)-1,14-dihydroxy-12-[(E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-17-prop-2-enyl-11,28-dioxa-4-azatricyclo[22.3.1.04,9]octacos-18-ene-2,3,10,16-tetrone. InChIKey: QJJXYPPXXYFBGM-XTNLUGHASA-N.

Dane identyfikacyjne
Wzór sumarycznyC44H69NO12
Masa molowa804.0 g/mol
Nazwa IUPAC(1S,9S,12S,13R,14S,17R,18E,21S,23S,24R,25S,27R)-1,14-dihydroxy-12-[(E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-17-prop-2-enyl-11,28-dioxa-4-azatricyclo[22.3.1.04,9]octacos-18-ene-2,3,10,16-tetrone
InChIKeyQJJXYPPXXYFBGM-XTNLUGHASA-N
SMILESC[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC

Dane obliczone przez PubChem (NCBI)

Synonimy: Tacrolimus 19-epimer, Tacrolimus anhydrous 19-epimer, Tacrolimus compound II [EP], Tacrolimus monohydrate impurity G [EP], TACROLIMUS COMPOUND II [EP IMPURITY], TACROLIMUS MONOHYDRATE IMPURITY G [EP IMPURITY], TACROLIMUS COMPOUND II (EP IMPURITY), TACROLIMUS MONOHYDRATE IMPURITY G (EP IMPURITY), Tacrolimus compound II, Tacrolimus monohydrate impurity G
Powiązane formy tego związku
(1R,9S,12S,13R,14S,17R,18E,21S,23S,24R,25S,27R)-1,14-dihydroxy-12-[(E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-17-prop-2-enyl-11,28-dioxa-4-azatricyclo[22.3.1.04,9]octacos-18-ene-2,3,10,16-tetrone C44H69NO12
(1R,9S,12S,13R,14S,17R,18Z,21S,23S,24R,25S,27R)-17-(3,3-dideuterio(313C)prop-2-enyl)-1,14-dihydroxy-12-[(E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.04,9]octacos-18-ene-2,3,10,16-tetrone C44H69NO12
(1R,9S,12S,13R,14S,17S,18E,21S,23S,24R,25S,27R)-1,14-dihydroxy-12-[(E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-17-prop-2-enyl-11,28-dioxa-4-azatricyclo[22.3.1.04,9]octacos-18-ene-2,3,10,16-tetrone C44H69NO12
Izomery (ten sam wzór sumaryczny)
(1R,9S,12S,15R,16E,19S,21S,22R,23R,25R)-1-hydroxy-12-[(E,2S,3S)-3-hydroxy-5-[(1R,3S,4R)-4-hydroxy-3-methoxycyclohexyl]-4-methylpent-4-en-2-yl]-21,23-dimethoxy-17,19,25-trimethyl-15-prop-2-enyl-11,26-dioxa-4-azatricyclo[20.3.1.04,9]hexacos-16-ene-2,3,10,14-tetrone C44H69NO12
(5R,7S,8R,9S,11S,13E,15R,18S,19R,20S,23S)-8,18-dihydroxy-20-[(E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl]-7,9-dimethoxy-5,11,13,19-tetramethyl-15-prop-2-enyl-21-oxa-1-azabicyclo[21.4.0]heptacos-13-ene-2,3,4,16,22-pentone C44H69NO12
(1R,2R,9S,12S,13R,14R,17R,18E,21S,23S,24R,28S)-2,14-dihydroxy-12-[(E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl]-23,28-dimethoxy-1,13,19,21-tetramethyl-17-prop-2-enyl-11,25-dioxa-4-azatricyclo[22.2.2.04,9]octacos-18-ene-3,10,16,26-tetrone C44H69NO12
(1R,2R,9S,12S,13R,14S,17R,18E,21S,23S,24R,28S)-2,14-dihydroxy-12-[(E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl]-23,28-dimethoxy-1,13,19,21-tetramethyl-17-prop-2-enyl-11,25-dioxa-4-azatricyclo[22.2.2.04,9]octacos-18-ene-3,10,16,26-tetrone C44H69NO12
(2S)-1-[2-[(2R,3R,5S,6R)-2-hydroxy-6-[(1S,3S,5E,7R,9E,11R,12S,13E)-12-hydroxy-14-[(1R,3R)-4-hydroxy-3-methoxycyclohexyl]-1-methoxy-3,5,11,13-tetramethyl-8-oxo-7-prop-2-enyltetradeca-5,9,13-trienyl]-5-methoxy-3-methyloxan-2-yl]-2-oxoacetyl]piperidine-2-carboxylic acid C44H69NO12
(18E)-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)prop-1-en-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-17-prop-2-enyl-11,28,29-trioxa-4-azatetracyclo[22.3.1.12,5.04,9]nonacos-18-ene-3,10,16-trione C44H69NO12
(1R,9S,12R,13E,15S,16S,19R,20E,23S,25S,26R,27S,29R)-1,16-dihydroxy-12-[(1R,3S,4R)-4-hydroxy-3-methoxycyclohexyl]-25,27-dimethoxy-13,15,21,23,29-pentamethyl-19-prop-2-enyl-11,30-dioxa-4-azatricyclo[24.3.1.04,9]triaconta-13,20-diene-2,3,10,18-tetrone C44H69NO12